CorVel Corporation $(CRVL)$ reported its financial results for the quarter and fiscal year ending March 31, 2025. The company's quarterly revenue reached $232 million, marking a significant increase from $207 million in the same quarter of the previous year. For the entire fiscal year, CorVel's revenue rose to $896 million, up from $795 million in the prior fiscal year. The earnings per share $(EPS)$ for the quarter climbed to $0.51, compared to $0.37 in the corresponding quarter last year. On an annual basis, EPS increased to $1.83, from $1.47 in the previous year. These EPS figures have been adjusted to account for a three-for-one stock split that occurred on December 24, 2024. CorVel's gross profit for the fourth quarter of fiscal year 2025 grew by 34% to $58.0 million, achieving a 25% gross margin. The company ended the quarter with $171 million in cash and cash equivalents and had no borrowings. Additionally, CorVel repurchased $9.0 million of its common stock during the quarter. In terms of business operations, CorVel continued its strategic investment in artificial intelligence $(AI)$ to enhance its communication platform and improve medical billing practices. AI initiatives are also helping to combat fraud and inefficiencies in care utilization. In the health market, CERIS, a part of CorVel, launched its first customer through a new strategic platform partnership and signed another agreement to expand its partner network. These efforts align with CorVel's strategy of combining organic product development with external partnerships, contributing to positive quarterly results.